Catalyst Wire Dossier Catalyst Wire Dossier

Pegsunercept

pegylated soluble TNF receptor I · Amgen
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Pegsunercept, covering 2009-03-06 to 2009-11-26. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of the Efficacy of Combination Treatment With Anakinra and Pegsunercept in Improving Rheumatoid Arthritis [Phase 2]

See pricing